Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Cancer Care Companion

for
Pediatric Cancer
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07278778

Recruiting

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

for
Type 1 Diabetes (T1D), Metabolic Diseases,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18 - 69

Code: NCT07699380

Phase 2, Recruiting

Intratumoral N17350 in Advanced Solid Tumors

for
Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative,
Location: Buffalo NY, Houston TX, San Diego CA, Los Angeles CA
Sponsor: Onchilles Pharma Inc

Sex: All

Age: 18+

Code: NCT07339176

Phase 1, Phase 2, Recruiting

Suprachoroidal Administration in Subjects With Metastases to the Choroid

for
Eye Cancer, Primary Cancer
Location: Boston MA, Miami FL, Cleveland OH, Ann Arbor MI,
Sponsor: Aura Biosciences

Sex: All

Age: 18+

Code: NCT06643884

Phase 2, Recruiting

Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

for
HER2 Expressing Solid Tumors
Location: New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT07192432

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Implementation of Support in the Care of Adults Living With Type 1 Diabetes

for
Type 1 Diabetes, Metabolic Disease, Endocrine System Diseases,
Location: Quebec, Montreal, Terrebonne
Sponsor: McGill University

Sex: All

Age: 18+

Code: NCT06069583

Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07630974

Phase 1, Phase 2, Recruiting

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Irving TX, Los Angeles CA
Sponsor: CStone Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06741644

Phase 1, Phase 2, Recruiting

Study of NTB-928 in R/R OC

for
Relapsed/Refractory Ovarian Carcinoma
Location: Lake Success NY, Birmingham AL, Omaha NE, Aurora CO,
Sponsor: TeneoSeven, Inc.

Sex: Female

Age: 18+

Code: NCT07690189

Phase 1, Recruiting

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

for
Solid Tumor, Adult, Malignant Solid Tumor,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06824363

Early Phase 1, Recruiting

Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)

for
Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT07197515

Recruiting

Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers

for
Advanced Cancer, Metastatic Cancer
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05204147

Phase 1, Recruiting

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

for
Malignant Neoplasm
Location: Montreal, Toronto, St Louis MO, San Antonio TX
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07600749

Phase 1, Recruiting

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

for
Malignant Solid Neoplasm
Location: The Bronx NY, Freehold NJ, Summit NJ, Pompton NJ,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 0+

Code: NCT06295367

Recruiting

Contrast-enhanced CBCT With C-arm HyperSight Technology

for
Advanced Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07648160

Recruiting

Using Tumor Models to Determine Treatments

for
Pancreatic Ductal Carcinoma, Advanced Cancer, Epithelial Tumor
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06813079

Phase 2, Recruiting

Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors

for
Prospective Observational Study, Gemcitabine, Docetaxel,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 21+

Code: NCT07662018

Recruiting

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

for
Cancer, Prostate Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07463833

Recruiting

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

for
Triple Negative Breast Cancer (TNBC),
Location: Toronto, Houston TX, San Antonio TX,
Sponsor: ProteinQure Inc.

Sex: All

Age: 18+

Code: NCT07190469

Phase 1, Recruiting

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency),
Location: New Haven CT, New York NY, Houston TX, Sacramento CA
Sponsor: Duke Street Bio Ltd

Sex: All

Age: 18+

Code: NCT06458712

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial